Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
DD94ZN
|
|||
Drug Name |
A166
|
|||
Drug Type |
Antibody drug conjugate
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1/2 | [1] | |
Company |
KLUS Pharma
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT03602079) Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of KLUS Pharma. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.